Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Dr Demilade Adedinsewo, a general non-invasive cardiologist, is dedicated to advancing women's heart health, cardiovascular disease prevention, and addressing cardiovascular health disparities. With a keen interest in leveraging digital tools for effective cardiovascular disease management, Dr. Adedinsewo currently holds the esteemed position of Mayo Clinic Florida Women's Health Scholar.In her… View more
Author(s): María Pilar Resano-Barrio , Ramón Arroyo-Espliguero , María Carmen Viana-Llamas , et al Added: 3 years ago
The WHO has established that coronary artery and cerebrovascular disease represent the main causes of premature death and disability in developed countries.1 However, the incidence and prevalence of cardiovascular and cerebrovascular disease is also increasing in developing countries as a result of population ageing and changes in lifestyle. For these reasons, the prevention and treatment of… View more
Job title: Cardiovascular Disease and Hospice & Palliative Medicine Fellow
Dr Sarah Godfrey, MD, MPH is acardiovascular disease and hospice and palliative medicine fellow at UT Southwestern Medical Center. She grew up in New Jersey, studied African and African American Studies at Harvard University, and then did the majority of her medical training at Columbia University (postbac program, medical school, MPH, and internal medicine residency). Her research focus is in… View more
Dr Michael Honigberg is a distinguished cardiologist and researcher based at Massachusetts General Hospital and serving as an Assistant Professor of Medicine at Harvard Medical School. With academic excellence from Princeton University, where he graduated summa cum laude and Phi Beta Kappa, he further honed his expertise, earning his MD from Harvard Medical School.Board-certified in cardiology,… View more
Author(s): Dan Gaiţă , Svetlana Moşteoru , Laurence S Sperling Added: 3 years ago
The increasing worldwide prevalence of diabetes mellitus (DM) means almost 360 million people are suffering from this disease (in 2011) and it is estimated to reach 552 million people by 2030.1 The latest European Action on Secondary Prevention by Intervention to Reduce Events (EuroASPIRE) study (2013) has revealed that the mean prevalence of DM in European patients with coronary artery disease … View more
Job title: Assistant Professor of Medicine
Neha J Pagidipati is an Assistant Professor of Medicine and cardiovascular disease prevention specialist. Since 2011, she has conducted research on cardiometabolic disease prevention, lifestyle modification and weight management. She is currently an NIH K12 scholar in Implementation and Dissemination Science. Dr Pagidipati is building the Duke Cardiometabolic Disease Prevention Program, which… View more
Improving Cardiovascular Health through Innovation The Cardiovascular Research Foundation (CRF) strives to improve the quality of life for patients with cardiovascular disease. Investigate CRF investigates early-stage technologies. We consult for new device and drug therapies, develop unique experimental models, and offer a full range of histopathology services and advanced cardiac imaging. … View more
Author(s): J Christoph Geller Added: 3 years ago
Cardiovascular disease is the leading cause of death worldwide. Elevated low-density lipoprotein (LDL) cholesterol levels, hypertension, diabetes and smoking are key modifiable risk factors.1,2 Published practice guidelines3–10 recommend aggressive treatment of individual risk factors and have defined thresholds for the initiation of and goals for treatment (see Table 1). These treatment… View more
Foreword

Article

Author(s): Sverre E Kjeldsen Added: 3 years ago
Cardiovascular disease causes 4.35 million deaths per year in Europe (49% of all deaths) and costs the EU an estimated €169 billion per year. Hypertension, which is defined as blood pressure (BP) above 140/90mmHg, is one of the most common treatable risk factors for cardiovascular disease. Almost half of all European adults aged 35–64 years have hypertension. Although it is well established that… View more